Personal information

No personal information available

Activities

Employment (1)

University Hospital Southampton: Southampton, Southampton, GB

2009-09-08 to present | Consultant Respiratory Physician (Respiratory Medicine)
Employment
Source: Self-asserted source
Thomas Daniels

Works (14)

Cardiovascular function in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A cross-sectional, observational, single-centre study

Journal of Cystic Fibrosis
2025-02 | Journal article
Contributors: Lauren J Clayton; Anthony I Shepherd; Jo Corbett; Maria Perissiou; Gary Connett; Julian Legg; Mark Allenby; Thomas Daniels; Don S Urquhart; Kelly A Mackintosh et al.
Source: check_circle
Crossref

Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework.

Respiratory Medicine
2025-02 | Journal article
Contributors: Robert D. Sandler; Alan Anderson; Tracy Barnett; Steve Bourke; Sarah Cameron; Stephen J. Chapman; Jocelyn Choyce; Thom Daniels; Tracey Daniels; Sophie Dawson et al.
Source: check_circle
Crossref

Peripheral muscle function and body composition in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: a cross-sectional, observational, single-centre study

2024-11-01 | Preprint
Contributors: Lauren Clayton J; Anthony Shepherd; Jo Corbett; Mathieu Gruet; Gary Connett; Mark Allenby; Julian Legg; Thomas Daniels; Don Urquhart S; Zoe Saynor L
Source: check_circle
Crossref

Standards for the care of people with cystic fibrosis (CF); Planning for a longer life

Journal of Cystic Fibrosis
2024-05 | Journal article
Contributors: Andrea Gramegna; Charlotte Addy; Lorna Allen; Egil Bakkeheim; Catherine Brown; Thomas Daniels; Gwyneth Davies; Jane C. Davies; Ken De Marie; Damian Downey et al.
Source: check_circle
Crossref

Clearing the Air: Assessing Healthcare Professionals' Awareness of Air Pollution's Health Consequences

Future Healthcare Journal
2024-04 | Journal article
Contributors: L Holtgrewe; D Yoon; C Johnes; S Holgate; L Orlando; J Bevan; Y Choudhury; C Soan; T Daniels
Source: check_circle
Crossref

Position paper: Models of post-transplant care for individuals with cystic fibrosis

Journal of Cystic Fibrosis
2023-05 | Journal article
Contributors: Edward McKone; Kathleen J. Ramos; Cecilia Chaparro; Joshua Blatter; Ramsey Hachem; Michael Anstead; Fanny Vlahos; Abby Thaxton; Sarah Hempstead; Thomas Daniels et al.
Source: check_circle
Crossref

Emergency department admissions during COVID-19: explainable machine learning to characterise data drift and detect emergent health risks

2021-05-29 | Other
Contributors: Christopher Duckworth; Francis P. Chmiel; Dan K. Burns; Zlatko D. Zlatev; Neil M. White; Thomas W. V. Daniels; Michael Kiuber; Michael J. Boniface
Source: check_circle
Crossref

Using explainable machine learning to identify patients at risk of reattendance at discharge from emergency departments

2020-12-04 | Other
Contributors: F. P. Chmiel; D. K. Burns; M. Azor; F. Borca; M. J. Boniface; Z. D. Zlatev; N. M. White; T. W. V. Daniels; M. Kiuber
Source: check_circle
Crossref

Some young adults with cystic fibrosis‐related diabetes may safely stop insulin without any adverse clinical sequelae

Diabetic Medicine
2020-07 | Journal article
Contributors: C. Ogbolu; I. Arregui‐Fresneda; T. Daniels; R. I. G. Holt
Source: check_circle
Crossref

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Molecular therapy : the journal of the American Society of Gene Therapy
2017-09 | Journal article
Contributors: Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J et al.
Source: Self-asserted source
Thomas Daniels via Europe PubMed Central

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Science (New York, N.Y.)
2016-11 | Journal article
Contributors: Bryant JM; Grogono DM; Rodriguez-Rincon D; Everall I; Brown KP; Moreno P; Verma D; Hill E; Drijkoningen J; Gilligan P et al.
Source: Self-asserted source
Thomas Daniels via Europe PubMed Central

Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.

The ISME journal
2016-05 | Journal article
Contributors: Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
Source: Self-asserted source
Thomas Daniels via Europe PubMed Central

Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease.

Chest
2014-07 | Journal article
Contributors: Barry PJ; Plant BJ; Nair A; Bicknell S; Simmonds NJ; Bell NJ; Shafi NT; Daniels T; Shelmerdine S; Felton I et al.
Source: Self-asserted source
Thomas Daniels via Europe PubMed Central

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2013-01 | Journal article
Contributors: Daniels TW; Rogers GB; Stressmann FA; van der Gast CJ; Bruce KD; Jones GR; Connett GJ; Legg JP; Carroll MP
Source: Self-asserted source
Thomas Daniels via Europe PubMed Central